Tiotropium bromide. Treatment of COPD, bronchodilator, muscarinic antagonist

Drugs of the Future

Volumn 25, Issue 7, 2000, Pages 693-699

  Norman, P ^a   Graul, A ^a   Rabasseda, X ^a   Castaner, J ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; IPRATROPIUM BROMIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; TIOTROPIUM BROMIDE;

ARTICLE; ASTHMA; BRONCHODILATING ACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; DOSE RESPONSE; DRUG ABSORPTION; DRUG METABOLISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; HUMAN; NONHUMAN; RISK FACTOR; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0033801899     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2000.025.07.584825     Document Type: Article

References (21)

1. Novel approaches and targets for treatment of chronic obstructive pulmonary disease
2. The future for tiotropium
3. Ba 679 BR, a novel long-acting anticholinergic bronchodilator
4. Characterisation of [3H]-Ba-679 BR, a slowly dissociating muscarinic antagonist, in human lung: Radioligand binding and autoradiographic mapping
5. Effect of Ba 679 BR, a novel long-acting anticholinergic agent, on cholinergic neurotransmission in guinea pig and human airways
6. Pharmacological profile of BA 679 BR, a new long acting anticholinergic bronchodilator
7. Tiotropium (Spiriva(TM)): Mechanistical considerations and clinical profile in obstructive lung disease
8. Tiotropium bromide (Ba 679), pharmacology and early clinical observations
9. The pharmacokinetic (PK) profile of tiotropium during long-term treatment in stable COPD
10. Ba-679-Br, a new long-acting antimuscarinic bronchodilator: A pilot dose-escalation study in COPD
11. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: A pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD)
12. The onset of spirometric response following once daily inhalation of tiotropium in patients with COPD
13. Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma
14. Bronchodilator effect of tiotropium in moderate-severe athmatics
15. The spirometric efficacy of once daily dosing with tiotropium in stable COPD
16. Superior efficacy of tiotropium (TIO) compared to ipratropium (IpBr) as a maintenance bronchodilator in COPD
17. Tiotropium (Spiriva(TM)): One year bronchodilator efficacy established with once daily dosing in COPD patients
18. Tiotropium (Spiriva(TM)), a new long-acting anticholinergic bronchodilator, improves dyspnea in patients with COPD